In the results of cytokine assays, the levels of IL-4, IL-10, and IL-17 were elevated in DLBCL patients treated with chemotherapeutic agents, and IFN-γ, TNF, IL-6, and IL-2 decreased (Figure 2). This evidence concerns the gene IFNG and diffuse large B-cell lymphoma.